Page last updated: 2024-09-02

morpholinoanthracycline mx2 and Adenocarcinoma

morpholinoanthracycline mx2 has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyamoto, K; Shinkai, H; Takahashi, H; Tokiwa, T; Uchida, T1

Other Studies

1 other study(ies) available for morpholinoanthracycline mx2 and Adenocarcinoma

ArticleYear
Comparative pharmacokinetics of KRN8602, a new morpholino anthracycline, and adriamycin in tumor-bearing mice.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:5

    Topics: Adenocarcinoma; Animals; Antibiotics, Antineoplastic; Brain Chemistry; Carubicin; Cell Survival; Chromatography, High Pressure Liquid; Colonic Neoplasms; Doxorubicin; Female; Intestine, Small; Kidney; Leukemia P388; Liver; Lung; Mice; Myocardium; Neoplasm Transplantation; Spleen; Tissue Distribution; Tumor Cells, Cultured

1996